Navigation Links
SNPs of ABC transporter genes linked to lung cancer risk
Date:12/21/2008

Individuals with particular variants of certain genes involved in metabolizing the most potent carcinogen found in cigarette smoke have an increased risk of developing lung cancer. That is the conclusion of a new study published in the February 1, 2009 issue of CANCER, a peer-reviewed journal of the American Cancer Society. The study's results may help shed light on how lung cancer develops and could have important implications for preventing smoking-related cancers.

Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) is a component of cigarette smoke that has been shown to cause lung cancer in rodents. Certain enzymes act to protect the body from this type of chemical by turning it into nontoxic forms or by transporting it from cells. For example, ATP-binding cassette transporters encoded by genes known as ABCB1 and ABCC1 are involved in eliminating carcinogens from the lungs, protecting them against inhaled toxins.

Researchers suspect that individuals with alterations in these genes might have an increased susceptibility to develop lung cancer. Recently, a team of scientists led by Dr. Daru Lu and Dr. Haijian Wang of the Fudan University in Shanghai identified common variants at the beginning and end of the ABC1 and ABCC1 genes. They then analyzed these variants in 500 patients with lung cancer and 517 cancer-free controls in a Chinese population.

The investigators found that certain variants were found much more often in individuals with lung cancer than in cancer-free controls. Patients who had the variant allele of either ABCB1 rs3842 or ABCC1 rs212090 had a significantly increased risk of developing lung cancer. The former variant was particularly associated with an increased risk of cancer in women and in individuals under age 60 years. It also was linked to a major type of lung cancer called adenocarcinoma.

Dr. Wang and his colleagues previously identified other common genetic vari
'/>"/>

Contact: David Sampson
david.sampson@cancer.org
American Cancer Society
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Transporters may help delay diabetes-related retinal damage
2. ThermoGenesis Introduces New Cell Separation Technology for Veterinary Use at Major Equine Convention
3. 11 New Cholesterol Genes Identified
4. Few Ontario women with invasive ovarian cancer referred for genetic testing of breast cancer genes
5. ThermoGenesis Corp. Provides Updated Information for Conference Call/Webcast to Discuss Management Transition
6. ThermoGenesis Corp. Schedules Conference Call/Webcast to Discuss Management Transition
7. ThermoGenesis Announces Management Transition; Provides Update on Operational Milestones
8. Organogenesis Receives Two Prestigious Awards for Economic Impact and Manufacturing Excellence
9. China West II Files Suit Against Genesis Pharmaceuticals and Capital Research Group Inc, Announces Conference Call Details
10. Genes May Predict Lymphoma Treatment Outcome
11. Researchers ID Suite of Genes in Aging Process
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)..., Dec. 4 The large, two-day free h... of Free Clinics (NAFC) in Kansas City on Wednesda...or anyone who is uninsured and has not seen a doct... will receive preventive primary care. ,, "Man...e clinic events this fall in Houston, New Orleans ...
(Date:12/4/2009).... 4 While Congress deba...h care costs, Leapfrog,s purchaser members point t...ring the best quality care in the nation while att...ur urban, eight children,s and three rural hospita...sed on results from The Leapfrog Hospital Survey. ...
(Date:12/4/2009)... new study shows that muscle cells grown in the la...ut properly. The work, performed in dogs and rats,...ons such as gastric reflux and fecal incontinence....ncters, which are the bands of muscle that separat...kness in these areas can cause gastrointestinal es...
(Date:12/4/2009)...icans are recruited annually to participate in cli...esearch Protection (AHRP), and most will be compen...stitutions view payments to volunteers as compensa...r potential risks related to participating in the ...s have a very different view of clinical trial com...
(Date:12/4/2009)...re done immediately or 3 weeks later, study shows ...iming of surgical repair or reconstruction of mult... outcome, a new study has found. , Multiple-lig...locations that can occur in high-impact car crashe...m surgery to repair these injuries hasn,t been def...
Breaking Medicine News(10 mins):Health News:Free Health Clinic Event Is Not Just for the Sick 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 4Health News:Human guinea pigs wary of high-paying medical trials 2Health News:Timing of Multiple-Ligament Knee Surgery May Not Matter 2
...nder 25 remains unclear, researchers say , ...erotonin reuptake inhibitors (SSRIs) may significa...cide in depressed adults, according to a review of...e World Health Organization and the University of ...
...y associated with muscle power and force in adoles...publication in The Endocrine Society,s Journal of... Although vitamin D is naturally produced in the b...ve a significant negative impact on muscle and bon...
...hnologies, Inc. ("Senesco" or the "Company") (NYSE...f efficacy, toxicological and dose-finding studies...andidate, SNS-01. SNS-01 is a nano-encapsulated c...asibility of long-term intravenous administration ...
...educe cravings, hunger levels, appetite, and food ... 3 Nutrition 21, Inc. (Nasdaq: NXXI ), the deve...r the Iceland Health(R) brand launched a potential...cted to reduce cravings, hunger levels, appetite, ...
... reduced overall death rates of patients hospitali... Hospital readmission rates for heart patients al...or hospital admissions in Virginia, and heart dise....vhi.org -- with quality comparisons among all Vi...
...gg producers are,unveiling "Incredible People," a ...the incredible edible egg(TM). The campaign remind...tein in the eggs they love provides them with,the ...n," said Kevin Burkum, senior vice president,of ma...
Other Medicine News:Health News:SSRI Antidepressants May Lower Adult Suicide Risk 2Health News:Vitamin D tied to muscle power in adolescent girls 2Health News:Senesco Announces Results of Pre-Clinical Efficacy, Toxicology and Dose Ranging Studies for Multiple Myeloma Therapeutic Candidate 2Health News:Senesco Announces Results of Pre-Clinical Efficacy, Toxicology and Dose Ranging Studies for Multiple Myeloma Therapeutic Candidate 3Health News:Senesco Announces Results of Pre-Clinical Efficacy, Toxicology and Dose Ranging Studies for Multiple Myeloma Therapeutic Candidate 4Health News:Nutrition 21 Launches Breakthrough Weight Management Product: Iceland Health(R) 'Appetite Control Formula' 2Health News:Nutrition 21 Launches Breakthrough Weight Management Product: Iceland Health(R) 'Appetite Control Formula' 3Health News:Nutrition 21 Launches Breakthrough Weight Management Product: Iceland Health(R) 'Appetite Control Formula' 4Health News:Virginia Hospitals Improve Heart Care--Death & Readmission Rates Decline 2Health News:America's Egg Farmers Launch New Incredible Edible Egg(TM) Advertising Campaign Focusing on 'Body And Mind' 2Health News:America's Egg Farmers Launch New Incredible Edible Egg(TM) Advertising Campaign Focusing on 'Body And Mind' 3
(Date:12/3/2009)... , , MADISON, N.J., Dec. 3 /PRNewswire-F... a patient,s risk of developing a potentially life...pharmaceutical therapies or chemicals is one of se...gnostics leader Quest Diagnostics (NYSE: DGX ) w...matology (ASH) Annual Meeting and Exposition, Dece...
(Date:12/3/2009)... , , DOYLESTOWN, Pa., Dec. 3 /PRNew...f The Quigley Corporation, (Nasdaq: QGLY ) www.q... completed its evaluation of its opportunities to ...ts and has concluded that it is in its best intere...rketplace, which may include but are not limited t...
(Date:12/3/2009)... , , WARRENDALE, Pa., Dec. 3 /P.... demonstrated PACS* injection-record integration ...y of North America in Chicago. The Connect.PACS(...tics capabilities of its kind, is the latest relea...formatics Platform . ,, (Photo: http://www....
Breaking Medicine Technology:Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 2Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 3Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 3MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 2MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 3SXC Health solutions announces record third quarter financial results 60754 1SXC Health solutions announces record third quarter financial results 60754 2SXC Health solutions announces record third quarter financial results 60754 3SXC Health solutions announces record third quarter financial results 60754 4SXC Health solutions announces record third quarter financial results 60754 5SXC Health solutions announces record third quarter financial results 60754 6SXC Health solutions announces record third quarter financial results 60754 7SXC Health solutions announces record third quarter financial results 60754 8SXC Health solutions announces record third quarter financial results 60754 9SXC Health solutions announces record third quarter financial results 60754 10SXC Health solutions announces record third quarter financial results 60754 11SXC Health solutions announces record third quarter financial results 60754 12SXC Health solutions announces record third quarter financial results 60754 13SXC Health solutions announces record third quarter financial results 60754 14SXC Health solutions announces record third quarter financial results 60754 15SXC Health solutions announces record third quarter financial results 60754 16SXC Health solutions announces record third quarter financial results 60754 17SXC Health solutions announces record third quarter financial results 60754 18SXC Health solutions announces record third quarter financial results 60754 19SXC Health solutions announces record third quarter financial results 60754 20Stereotaxis Reports 26 25 Third Quarter 2009 Revenue Growth 60749 1Stereotaxis Reports 26 25 Third Quarter 2009 Revenue Growth 60749 2Stereotaxis Reports 26 25 Third Quarter 2009 Revenue Growth 60749 3Stereotaxis Reports 26 25 Third Quarter 2009 Revenue Growth 60749 4Stereotaxis Reports 26 25 Third Quarter 2009 Revenue Growth 60749 5Stereotaxis Reports 26 25 Third Quarter 2009 Revenue Growth 60749 6Stereotaxis Reports 26 25 Third Quarter 2009 Revenue Growth 60749 7Stereotaxis Reports 26 25 Third Quarter 2009 Revenue Growth 60749 8BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 14731 1BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 14731 2BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 14731 3BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 14731 4
...ld-Standard for Renal Cell Carcinoma in 2012, Acco... WALTHAM, Mass., Feb. 26 Decision Resources, one ... for pharmaceutical and healthcare issues, finds t... carcinoma that can increase overall survival in c...cent patient share in the United States and a 35 p...
...Alternext: ALEHT) is pleased to announce that clin...eimer,s disease, is progressing well. Patient,enro...n patients with,Alzheimer,s disease is completed. ...ent for the Phase IIa,represents an important mile... a clear timeline for the release of results," sta...
Other Medicine Technology:A First-Line Therapy for Renal Cell Carcinoma that can Increase Overall Survival when Compared with Sutent Would Earn a Higher Patient Share in the United States Than in Europe 2A First-Line Therapy for Renal Cell Carcinoma that can Increase Overall Survival when Compared with Sutent Would Earn a Higher Patient Share in the United States Than in Europe 3ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimer's Disease 2ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimer's Disease 3ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimer's Disease 4
Complete brand Blink-N-Clean Lens Drops
Renu Preservative Free Lubricating and Rewetting Drops
Sterile Preserved Saline Solution
Sensitive Eyes Plus Saline Solution
Medicine Products: